Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation.

Rodger E. Tiedemann, MD, PhD, Natalia Gonzalez-Paz, MD, Rafael Santana-Davila, MD, Wee Joo Chng, MD, Rhett Ketterling, MD, Morie A. Gertz, MD, Tammy Price-Troska, Kimberly Henderson, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Angela Dispenzieri, MD, Martha Lacy, MD, Rafael Fonseca, MD

Blood (2006) 108 (11): 3587.

https://doi.org/10.1182/blood.V108.11.3587.3587

Published: 2006

Journal Articles

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Natalia Gonzalez-Paz, Wee J. Chng, Rebecca F. McClure, Emily Blood, Martin M. Oken, Brian Van Ness, C. David James, Paul J. Kurtin, Kimberly Henderson, Gregory J. Ahmann, Morie Gertz, Martha Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2006) 109 (3): 1228–1232.

https://doi.org/10.1182/blood-2006-05-024661

Published: 2006

Journal Articles

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Robert Kyle, MD, Philip Greipp, MD, Rafael Fonseca, MD, Peter Leif Bergsagel, MD

Blood (2005) 106 (11): 3381.

https://doi.org/10.1182/blood.V106.11.3381.3381

Published: 2005

Journal Articles

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1537.

https://doi.org/10.1182/blood.V106.11.1537.1537

Published: 2005

Journal Articles

6q Deletion in Waldenström Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival.

Roelandt F.J. Schop, MD, Enrique M. Ocio, MD, Belen Gonzalez, MD, PhD, Norma C. Gutierrez, MD, PhD, Maria Jesus Moro, MD, Carmen Aguilera, MD, Jose Hernández, MD, Ramon García-Sanz, MD, PhD, Ruifang Xu, PhD, Jesus M. Hernandez-Rivas, MD, Ph.D, Philip R. Greipp, MD, Angela Dispenzieri, MD, Syed M. Jalal, PhD, Martha Q. Lacy, MD, Natalia Gonzalez-Paz, MD, Morie A. Gertz, MD, Jesús F. San Miguel, MD, PhD, Rafael Fonseca, MD

Blood (2005) 106 (11): 986.

https://doi.org/10.1182/blood.V106.11.986.986

Published: 2005

Journal Articles

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Rafael Fonseca, MD, Scott Van Wier, Wee-Joo Chng, MD, Rhett Ketterling, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, S. Vincent Rajkumar, MD, Philip Greipp, MD, Mark Litzow, MD, Shaji Kumar, MD, Natalia Gonzalez-Paz, MD, Kim Henderson, Gregory Ahmann, Morie Gertz, MD

Blood (2005) 106 (11): 624.

https://doi.org/10.1182/blood.V106.11.624.624

Published: 2005

Journal Articles

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis

Roshini S. Abraham, Karla V. Ballman, Angela Dispenzieri, Diane E. Grill, Michelle K. Manske, Tammy L. Price-Troska, Natalia Gonzalez Paz, Morie A. Gertz, Rafael Fonseca

Blood (2005) 105 (2): 794–803.

https://doi.org/10.1182/blood-2004-04-1424

Published: 2005

NARROW

Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation.

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

6q Deletion in Waldenström Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival.

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation.

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

6q Deletion in Waldenström Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival.

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only